BioAlliance Pharma SA today announces, following the end of the European Mutual Recognition Procedure last December (with France as Reference Member State) that it has just received the Marketing Authorisation for Loramyc in the UK and Denmark.
IDGLOBAL's business model of delivering and showcasing its Nano-Molecular Markers for Anti-Counterfeiting and IDFORENSIX for Anti-Theft/loss prevention products will continue through an aggressive tradeshow and conference schedule throughout the 2008 fiscal year. Revenues and the roster of clients for its Nano-Molecular Markers has grown significantly in fiscal year 2007 and IDGLOBAL is engaged in multiple pilot projects, proposals and early stage discussions with a number of Fortune 100 companies.
Thermo Fisher Scientific Inc. announces that it has been awarded a US Patent on Spectrometric Data Cleansing. This patent describes a method for filtering artifacts from Raman spectra and is of particular use in removing the distorted data points generated by cosmic ray interference. Elimination of spectral artifacts facilitates automated analysis by such methods as reference library searches and correlation with standard spectra.
API Nanotronics Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, today announced record orders totaling over $2.6 million for the month of December 2007.
Nanophase Technologies, a technology leader in nanomaterials and advanced nanoengineered products, announces that the Company has been issued U.S. Patent No. 7,303,891 - entitled 'Surface Treatment of Nanoparticles to Control Interfacial Properties and Method of Manufacture'.
Green Earth Technologies today announced the completion of an investment of $2.1 million from Founder's Technology and eight angel investors for 4,318,750 common shares, at $0.20 and $300,000 in short term straight debt. Proceeds from the capital raise will be used to fund working capital requirements.
AMAG Pharmaceuticals, Inc. today announced that Brian J.G. Pereira, MD, President and CEO of AMAG Pharmaceuticals, Inc., will provide a company update at the 26th Annual JPMorgan Healthcare Conference at 11:00 a.m. PT on Tuesday, January 8, 2008, in San Francisco, CA.
JPK Instruments AG, one of the leading developers of measuring and analytical instruments in the nanotechnology field, has increased its share in JPK subsidiary nAmbition GmbH in Dresden to 100 percent. Thus the Berlin-based company was able to extend its product portfolio and significantly boost its Molecular Analytics division.